This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (330)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Oncology  • Cervical Cancer  • Dermatology  • Dermatologic Disorders  • Papillomavirus, Human  • Alert me on articles by topic  Social Bookmarking   What's this?

Using Human Papillomavirus DNA Testing for Equivocal Papanicolaou Results

M. Michele Manos, PhD, MPH; Walter K. Kinney, MD; Leo B. Hurley, MPH; Mark E. Sherman, MD; Jen Shieh-Ngai, MS; Robert J. Kurman, MD; Janice E. Ransley, MD; Barbara J. Fetterman, SCT (ASCP); James S. Hartinger, CT (ASCP); Karen M. McIntosh, MD; Gene F. Pawlick, MD; Robert A. Hiatt, MD, PhD

JAMA. 1999;281:1605-1610.

Context  A Papanicolaou (Pap) test result of atypical squamous cells of undetermined significance (ASCUS) presents a clinical challenge. Only 5% to 10% of women with ASCUS harbor serious cervical disease, but more than one third of the high-grade squamous intraepithelial lesions (HSILs) in screening populations are identified from ASCUS Pap test results.

Objective  To determine whether human papillomavirus (HPV) DNA testing of residual material from liquid-based Pap tests and referral of cases found to be HPV-positive directly to colposcopy could provide sensitive detection of underlying HSILs in women with ASCUS Pap results, compared with repeat Pap testing.

Design and Setting  Natural history of women with ASCUS Pap smear results, all of whom had liquid-based cytology, HPV testing, and subsequent repeat Pap tests and colposcopy with histologic evaluation, conducted at 12 gynecology clinics in a large managed care organization between October 1995 and June 1996.

Participants  From a cohort of 46,009 women who had routine cervical examinations, 995 women with Pap test results of ASCUS who consented to participate were identified.

Main Outcome Measures  Cervical histology, HPV test results, and repeat Pap smear results, and sensitivity of HPV testing to identify patients found to have HSIL+ histology.

Results  Of 995 participants with ASCUS Pap test results, 973 had both a definitive histologic diagnosis and HPV result. Sixty-five (6.7%) had histologic HSIL or cancer. For women with histologic HSIL+, the HPV test was positive in 89.2% (95% confidence interval [CI], 78.4%-95.2%), and the specificity was 64.1% (95% CI, 60.9%-67.2%). The repeat Pap smear result was abnormal in 76.2% (95% CI, 63.5%-85.7%). Triage based on HPV testing only or on repeat Pap testing only would refer similar proportions (approximately 39%) to colposcopy. The sensitivity of HPV DNA testing for HSIL was equivalent to, if not greater than, that of the repeat Pap test. We further estimated that an HPV-based algorithm including the immediate colposcopy of HPV-positive women, and then repeat Pap testing of all others, would provide an overall sensitivity of 96.9% (95% CI, 88.3%-99.5%).

Conclusions  For women with ASCUS Pap tests, HPV DNA testing of residual specimens collected for routine cervical cytology can help identify those who have underlying HSIL. By testing the specimen collected at initial screening, the majority of high-risk cases can be identified and referred for colposcopy based on a single screening.

Author Affiliations: Division of Research (Drs Manos and Hiatt and Mr Hurley), Division of Gynecologic Oncology (Dr Kinney), Department of Pathology (Dr Ransley), and Regional Laboratory (Mss Shieh-Ngai and Fetterman, Mr Hartinger, and Drs McIntosh and Pawlick), Northern California Kaiser Permanente Medical Group, Oakland; and Departments of Pathology and Obstetrics and Gynecology, The Johns Hopkins Medical Institutions, Baltimore, Md (Drs Sherman and Kurman).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

Evaluating the Role of HPV Testing for Women With Equivocal Papanicolaou Test Findings
J. Thomas Cox
JAMA. 1999;281(17):1645-1647.
EXTRACT | FULL TEXT  

May 5, 1999
JAMA. 1999;281(17):1663-1664.
EXTRACT | FULL TEXT  

The importance of a Pap test
JAMA. 1999;281(17):1666.
PDF  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Comparison of Cytology, Colposcopy, HPV Typing and Biomarker Analysis in Cervical Neoplasia
ADAMOPOULOU et al.
Anticancer Res 2009;29:3401-3409.
ABSTRACT | FULL TEXT  

Human Papillomavirus in Cervical Cancer Screening: Important Role as Biomarker
Boulet et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:810-817.
ABSTRACT | FULL TEXT  

Genotyping of Human Papillomaviruses by a Novel One-Step Typing Method with Multiplex PCR and Clinical Applications
Nishiwaki et al.
J. Clin. Microbiol. 2008;46:1161-1168.
ABSTRACT | FULL TEXT  

Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer
Mayrand et al.
NEJM 2007;357:1579-1588.
ABSTRACT | FULL TEXT  

Evaluation of Combined General Primer-Mediated PCR Sequencing and Type-Specific PCR Strategies for Determination of Human Papillomavirus Genotypes in Cervical Cell Specimens
Fontaine et al.
J. Clin. Microbiol. 2007;45:928-934.
ABSTRACT | FULL TEXT  

High concordance of results of testing for human papillomavirus in cervicovaginal samples collected by two methods, with comparison of a novel self-sampling device to a conventional endocervical brush.
Brink et al.
J. Clin. Microbiol. 2006;44:2518-2523.
ABSTRACT | FULL TEXT  

Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial.
Ronco et al.
JNCI J Natl Cancer Inst 2006;98:765-774.
ABSTRACT | FULL TEXT  

Development of a sensitive and specific assay combining multiplex PCR and DNA microarray primer extension to detect high-risk mucosal human papillomavirus types.
Gheit et al.
J. Clin. Microbiol. 2006;44:2025-2031.
ABSTRACT | FULL TEXT  

Comparison between the Hybrid Capture II Test and an SPF1/GP6+ PCR-Based Assay for Detection of Human Papillomavirus DNA in Cervical Swab Samples.
Huang et al.
J. Clin. Microbiol. 2006;44:1733-1739.
ABSTRACT | FULL TEXT  

Oncogenic Human Papillomavirus (HPV) Type Distribution and HPV Type 16 E6 Variants in Two Spanish Population Groups with Different Levels of HPV Infection Risk
Ortiz et al.
J. Clin. Microbiol. 2006;44:1428-1434.
ABSTRACT | FULL TEXT  

Human Papillomavirus Triage of Atypical Squamous Cells of Undetermined Significance: Cost-Effective, But At What Cost?
Melnikow and Birch
JNCI J Natl Cancer Inst 2006;98:82-83.
FULL TEXT  

Acceptability of human papillomavirus self testing in female adolescents
Kahn et al.
Sex. Transm. Infect. 2005;81:408-414.
ABSTRACT | FULL TEXT  

Human Papillomavirus Type 16 Infections and 2-Year Absolute Risk of Cervical Precancer in Women With Equivocal or Mild Cytologic Abnormalities
Castle et al.
JNCI J Natl Cancer Inst 2005;97:1066-1071.
ABSTRACT | FULL TEXT  

Human Papillomavirus Testing with the Hybrid Capture 2 Assay and PCR as Screening Tools
Kulmala et al.
J. Clin. Microbiol. 2004;42:2470-2475.
ABSTRACT | FULL TEXT  

Self-testing for human papillomavirus using a vaginal swab: placing prevention of cervical cancer in the patient's hands
Kahn
Ann Oncol 2004;15:847-849.
FULL TEXT  

Virologic Versus Cytologic Triage of Women With Equivocal Pap Smears: A Meta-analysis of the Accuracy To Detect High-Grade Intraepithelial Neoplasia
Arbyn et al.
JNCI J Natl Cancer Inst 2004;96:280-293.
ABSTRACT | FULL TEXT  

Human Papillomavirus Type 16 E6 and E7 Cause Polyploidy in Human Keratinocytes and Up-Regulation of G2-M-Phase Proteins
Patel et al.
Cancer Res. 2004;64:1299-1306.
ABSTRACT | FULL TEXT  

Case 32-2003 - A 37-Year-Old Woman with Atypical Squamous Cells on a Papanicolaou Smear
Goodman and Wilbur
NEJM 2003;349:1555-1564.
FULL TEXT  

Chapter 12: Human Papillomavirus Technologies
Iftner and Villa
J Natl Cancer Inst Monogr 2003;2003:80-88.
ABSTRACT | FULL TEXT  

Chapter 14: Role of Triage Testing in Cervical Cancer Screening
Solomon
J Natl Cancer Inst Monogr 2003;2003:97-101.
ABSTRACT | FULL TEXT  

Cross sectional study of conventional cervical smear, monolayer cytology, and human papillomavirus DNA testing for cervical cancer screening
Coste et al.
BMJ 2003;326:733-733.
ABSTRACT | FULL TEXT  

Human Papillomavirus and Cervical Cancer
Burd
Clin. Microbiol. Rev. 2003;16:1-17.
ABSTRACT | FULL TEXT  

A Framework for Improving the Quality of Cancer Care: The Case of Breast and Cervical Cancer Screening
Zapka et al.
Cancer Epidemiol. Biomarkers Prev. 2003;12:4-13.
ABSTRACT | FULL TEXT  

Evaluation of Human Papillomavirus Testing in Primary Screening for Cervical Abnormalities: Comparison of Sensitivity, Specificity, and Frequency of Referral
Kulasingam et al.
JAMA 2002;288:1749-1757.
ABSTRACT | FULL TEXT  

Costs and Benefits of Different Strategies to Screen for Cervical Cancer in Less-Developed Countries
Mandelblatt et al.
JNCI J Natl Cancer Inst 2002;94:1469-1483.
ABSTRACT | FULL TEXT  

Detection of Viral Infection and Gene Expression in Clinical Tissue Specimens Using Branched DNA (bDNA) In Situ Hybridization
Kenny et al.
J. Histochem. Cytochem. 2002;50:1219-1227.
ABSTRACT | FULL TEXT  

Benefits and Costs of Using HPV Testing to Screen for Cervical Cancer
Mandelblatt et al.
JAMA 2002;287:2372-2381.
ABSTRACT | FULL TEXT  

Cost-effectiveness of Alternative Triage Strategies for Atypical Squamous Cells of Undetermined Significance
Kim et al.
JAMA 2002;287:2382-2390.
ABSTRACT | FULL TEXT  

2001 Consensus Guidelines for the Management of Women With Cervical Cytological Abnormalities
Wright et al.
JAMA 2002;287:2120-2129.
ABSTRACT | FULL TEXT  

The causal relation between human papillomavirus and cervical cancer
Bosch et al.
J. Clin. Pathol. 2002;55:244-265.
ABSTRACT | FULL TEXT  

Effects of Age and Human Papilloma Viral Load on Colposcopy Triage: Data From the Randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS)
Sherman et al.
JNCI J Natl Cancer Inst 2002;94:102-107.
ABSTRACT | FULL TEXT  

Molecular Diagnosis of Skin-Associated Infectious Agents
Payne et al.
Arch Dermatol 2001;137:1497-1502.
ABSTRACT | FULL TEXT  

HPV for Cervical Cancer Screening: Is the Era of the Molecular Pap Smear Upon Us?
Stoler
J. Histochem. Cytochem. 2001;49:1197-1198.
ABSTRACT | FULL TEXT  

Single-copy Gene Detection Using Branched DNA (bDNA) In Situ Hybridization
Player et al.
J. Histochem. Cytochem. 2001;49:603-612.
ABSTRACT | FULL TEXT  

HPV testing for clarifying borderline cervical smear results
Manos
BMJ 2001;322:878-879.
FULL TEXT  

Human papillomavirus testing and the management of women with mildly abnormal cervical smears: an observational study
Rebello et al.
BMJ 2001;322:893-894.
FULL TEXT  

Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection
Franco et al.
CMAJ 2001;164:1017-1025.
ABSTRACT | FULL TEXT  

Papillomavirus research update: highlights of the Barcelona HPV 2000 international papillomavirus conference
Bosch et al.
J. Clin. Pathol. 2001;54:163-175.
ABSTRACT | FULL TEXT  

Comparison of Three Management Strategies for Patients With Atypical Squamous Cells of Undetermined Significance: Baseline Results From a Randomized Trial
Solomon et al.
JNCI J Natl Cancer Inst 2001;93:293-299.
ABSTRACT | FULL TEXT  

High-Risk and Multiple Human Papillomavirus Infections Associated with Cervical Abnormalities in Japanese Women
Sasagawa et al.
Cancer Epidemiol. Biomarkers Prev. 2001;10:45-52.
ABSTRACT | FULL TEXT  

A higher level of human papillomavirus 16 DNA was associated with an increased risk for cervical carcinoma in situ
Melnikow and Nuovo
Evid. Based Med. 2001;6:29-29.
FULL TEXT  

Persistently high loads of human papillomavirus 16 over time were associated with an increased risk for cervical cancer
Melnikow and Nuovo
Evid. Based Med. 2001;6:30-30.
FULL TEXT  

Screening for cervical cancer: Should we test for infection with high-risk HPV?
Meijer et al.
CMAJ 2000;163:535-538.
FULL TEXT  

Accuracy of the Papanicolaou Test in Screening for and Follow-up of Cervical Cytologic Abnormalities: A Systematic Review
Nanda et al.
ANN INTERN MED 2000;132:810-819.
ABSTRACT | FULL TEXT  

Emerging Technologies and Cervical Cancer
Follen and Richards-Kortum
JNCI J Natl Cancer Inst 2000;92:363-365.
FULL TEXT  

Cervical cytology after 2000: where to go?
Meijer and Walboomers
J. Clin. Pathol. 2000;53:41-43.
FULL TEXT  

Detection of High-Risk Cervical Intraepithelial Neoplasia and Cervical Cancer by Amplification of Transcripts Derived from Integrated Papillomavirus Oncogenes
Klaes et al.
Cancer Res. 1999;59:6132-6136.
ABSTRACT | FULL TEXT  

Evaluating ASCUS with HPV Typing
JWatch Women's Health 1999;1999:4-4.
FULL TEXT  

Evaluating Women with Equivocal Pap Smears
Journal Watch Dermatology 1999;1999:17-17.
FULL TEXT  

Evaluating Women with Equivocal Pap Smears
JWatch General 1999;1999:3-3.
FULL TEXT  

Evaluating the Role of HPV Testing for Women With Equivocal Papanicolaou Test Findings
Cox
JAMA 1999;281:1645-1647.
FULL TEXT